CURRENT PRODUCT
PROBLEMS
When used, currently available collagen-based specialist wound and bone related products often suffer from a number of issues –
Uncontrollable levels of swelling.
Poor mechanical properties.
Fast breakdown.
These lead to unsatisfactory clinical outcomes, additional healthcare costs and diminished quality of life for patients.
These lead to unsatisfactory clinical outcomes, additional healthcare costs and diminished quality of life for patients.
Unsatisfactory clinical outcomes also lead to a lack of confidence and reduced adoption of those products by healthcare professionals, thus restricting industry growth.
THE HYFACOL
SOLUTION
HYFACOL manufactured guided bone regeneration membranes last 50% longer than the current gold standard, minimising risks of unnecessary additional surgery.
HYFACOL employs a range of bespoke, patented manufacturing processes to create wound dressings with superior clinical performance.
Our patient-focused development approach ensures our technology solves the problems that prevent nearly 90% of the total advanced wound dressing market from adopting clinically valuable collagen-based solutions.
Significantly improve the results for patients being treated with wound care and GBR products.
Significantly reduce the cost of treatment, not least by reducing the treatment timeframe and number of treatment attempts.
Offer a reliable treatment option to clinicians, significantly increasing buy-in for this type of product.